S.-H. Song et al. / Tetrahedron Letters 53 (2012) 7075–7077
7077
Ni2+
O
O
O
2
NH2NH2.H2O
NiCl2.6H2O
Ni2+
NH NH2
NH2
NH
NH
O
O
O
1
O
Ni2+
-NH3
NH
NH
O
O
Ar
6
O
N
Ar
-NiCl2.6H2O
X
N
N
X
O
3
NH CN
NiCl2.6H2O
X
CN
NH
NC
O
CHAr
+
Ni2+
X
7
ArCHO
4
O
O
Ar
N
N
X
5
NH2
Scheme 1. A plausible reaction mechanism.
entry 1); while 3-nitrobenzaldehyde and 2-nitrobenzaldehyde
provided the product in 90% and 85% yields, respectively (Table 2,
entries 2 and 3). The decrease of yields was likely that the steric
effect of nitro group increased from para position to ortho
position. Similarly, 3-chlorobenzaldehyde gave a better yield than
2-chlorobenzaldehyde (Table 2, entries 6 and 7). This trend also
was found using 4-bromobenzaldehyde and 3-bromobenzaldehyde
(Table 2, entries 8 and 9). However there was an exception that
4-chlorobenzaldehyde provided a relatively low yield of 80%
(Table 2, entry 5) than 3-chlorobenzaldehyde. Overall this
procedure was applicable to various F, Cl, and Br substituted
benzaldehydes which gave satisfactory yields (Table 2, entries
4–9). The high yields of products could be obtained from
benzaldehyde and aromatic aldehydes bearing electron-donating
groups as well. In addition, the four-component reactions
using ethyl cyanoacetate (Table 2, entries 13–17) instead of
malononitrile generally gave good yields except reacting with
4-fluorobenzaldehyde (Table 2, entry 14).
A plausible mechanism was proposed for the formation of 1H-
pyrazolo[1,2-b]phthalazine-5,10-diones from the four-component
condensation reaction of phthalimide, hydrazine hydrate, malono-
nitrile, and aromatic aldehydes (Scheme 1). In the presence of a
catalyst, phthalimide 1 reacts with hydrazine hydrate 2 to generate
phthalhydrazide 6. Meanwhile, the Knoevenagel condensation
of malononitrile or ethyl cyanoacetate 3 with aldehyde 4
produces intermediate 7. Subsequently, Michael-type addition of
phthalhydrazide 6 and intermediate 7 followed by cyclization
affords the corresponding product 5.
Supplementary data
Supplementary data associated with this article can be found, in
References and notes
1. Franklin, E. C. Chem. Rev. 1935, 16, 305–361.
2. Bergstrom, F. W. Chem. Rev. 1944, 35, 77–277.
3. Lichtenthaler, F. W. Acc. Chem. Res. 2002, 35, 728–737.
4. Nabid, M. R.; Rezaei, S. J. T.; Ghahremanzadeh, R.; Bazgir, A. Ultrason. Sonochem.
2010, 17, 159–161.
5. Terrett, N. K.; Bell, A. S.; Brown, D.; Ellis, P. Bioorg. Med. Chem. Lett. 1996, 6,
1819–1824.
6. Elguero, J. In Comprehensive Heterocyclic Chemistry II; Katritzky, A. R., Rees, C.
W., Scriven, E. F., Eds.; Elsevier: Oxford, 1996; Vol. 3, pp 1–75.
7. Singh, S. K.; Reddy, P. G.; Rao, K. S.; Lohray, B. B.; Misra, P.; Rajjak, S. A.; Rao, Y.
K.; Venkatewarlu, A. Bioorg. Med. Chem. Lett. 2004, 14, 499–504.
8. (a) Genin, M. J.; Biles, C.; Keiser, B. J.; Poppe, S. M.; Swaney, S. M.; Tarpley, W.
G.; Yagi, Y.; Romero, D. L. J. Med. Chem. 2000, 43, 1034–1040; (b) O’Hagan, D. J.
Fluorine Chem. 2010, 131, 1071–1081.
9. Grasso, S.; DeSarro, G.; Micale, N.; Zappala, M.; Puia, G.; Baraldi, M.; Demicheli,
C. J. Med. Chem. 2000, 43, 2851–2859.
10. Nomoto, Y.; Obase, H.; Takai, H.; Teranishi, M.; Nakamura, J.; Kubo, K. Chem.
Pharm. Bull. 1990, 38, 2179–2183.
11. Watanabe, N.; Kabasawa, Y.; Takase, Y.; Matsukura, M.; Miyazaki, K.; Ishihara,
H.; Kodama, K.; Adachi, H. J. Med. Chem. 1998, 41, 3367–3372.
12. (a) Chebanov, V. A.; Muravyova, E. A.; Desenko, S. M.; Musatov, V. I.; Knyazeva,
I. V.; Shishkina, S. V.; Shishkin, O. V.; Kappe, C. O. J. Comb. Chem. 2006, 8, 427–
434; (b) Dondoni, A.; Massi, A.; Sabbatini, S.; Bertolasi, V. J. Org. Chem. 2002, 67,
6979–6994.
13. Liu, J. N.; Li, J.; Zhang, L.; Song, L. P.; Zhang, M.; Cao, W. G.; Zhu, S. Z.; Deng, H.
G.; Shao, M. Tetrahedron Lett. 2012, 53, 2469–2472.
14. Kim, J. S.; Rhee, H. K.; Park, H. J.; Lee, S. K.; Lee, C. O.; Park Choo, H-Y. Bioorg.
Med. Chem. 2008, 16, 4545–4550.
15. El-Sakka, S. S.; Soliman, A. H.; Imam, A. M. Afinidad 2009, 66, 167.
16. Ryu, C. K.; Park, R. E.; Ma, M. Y.; Nho, J. H. Bioorg. Med. Chem. Lett. 2007, 17,
2577–2580.
Conclusion
17. Li, J.; Zhao, Y. F.; Yuan, X. Y.; Xu, J. X.; Gong, P. Molecules 2006, 11, 574–582.
18. Sinkkonen, J.; Ovcharenko, V.; Zelenin, K. N.; Bezhan, I. P.; Chakchir, B. A.; Al-
Assar, F.; Pihlaja, K. Eur. J. Org. Chem. 2002, 13, 2046–2053.
In summary, we have developed a one-pot four-component
reaction for the synthesis of pyrazolo[1,2-b]phthalazine-5,10-
diones from readily available starting materials. This method has
the advantages of being concise, highly efficient, friendly to the
environment, and inexpensive.
19. Jain, R. P.; Vederas, J. C. Bioorg. Med. Chem. Lett. 2004, 14, 3655–3658.
20. Kumar, A.; Gupta, M. K.; Kumar, M. Green Chem. 2012, 14, 290–295.
21. Ghahremanzadeh, R.; Shakibaei, G. I.; Bazgir, A. Synlett 2008, 1129–1132.
22. Raghuvanshi, D. S.; Singh, K. N. Tetrahedron Lett. 2011, 52, 5702–5705.
23. General procedure for the synthesis of phthalazine derivatives 5: A mixture of
phthalimide (1.0 mmol), hydrazine hydrate (1.0 mmol), and NiCl2Á6H2O
(0.1 mmol) in ethanol (3.0 mL) was stirred under reflux for 2 h. Then
aromatic aldehyde (1.0 mmol), malononitrile, or ethyl cyanoacetate
(1.0 mmol) were added, and the mixture was refluxed for a specified time.
The reaction was monitored by TLC. After the reaction completed, the reaction
mixture was allowed to cool to rt. The residue precipitated during the process
was separated from the solution by filtration, and the filter cake was washed
with ethanol to yield NMR pure 5.
Acknowledgments
Financial support from 2011 Select Project in Scientific and
Technological Activities for Returned Scholars of Chongqing Per-
sonnel Bureau, and the Doctoral Foundation of Southwest Univer-
sity (SWU112019) is gratefully acknowledged.